The Disease Forecasting Company.
Read More →
Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels
The West should be on a war footing for the next pandemic
Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity
From resistance to resilience: what could the future antibiotic pipeline look like?
Airfinity further expands into APAC with launch of Japan office
View All →
First Ozempic-style weight-loss pill could be available within two years
i newspaper | Sep 6, 2024
Countries should act faster to curb the spread of mpox
The Economist | Aug 22, 2024
BioNTech/Pfizer Covid and flu combo vaccine falters in late-stage trial
Financial Times | Aug 16, 2024
RSV vaccine market to decline 64% on CDC decision: report
Seeking Alpha | Jul 27, 2024
View All →
What's happening in a given disease area?
Airfinity is the most comprehensive, single source of intelligence for new developments in your chosen area.
Identify the true need for a vaccine or a treatment.
Our suite of dynamic predictive indicators help you navigate highly dynamic and uncertain market developments and see the real opportunities.
Maximise impact to save lives
Our analytics and probabilistic tools inform key decisions on resource allocation, investment and procurement decisions to maximise impact of a given drug or vaccine and ultimately improve as many lives as possible.
Airfinity develops and deploys dynamic disease forecasting models to support horizon scanning, medical countermeasure impact modelling, clinical trial site optimisation, scenario-based demand intelligence, portfolio optimisation and more.
“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”
Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister
“Airfinity has been instrumental in our country's COVID response.”
Head of UK Government
Vaccine Task Force
In a dynamic environment, Airfinity enabled us to remain on track with daily developments to enable more accurate decision-making. Airfinity combines nimbleness of real time data and their group of scientists that can analyse, model and provide strategic analysis for critical decision making.”
Iskra Reic, Executive Vice-President
Astrazeneca
“Probably the most expansive, accurate and helpful of the multiple data sets on an international scale”
Sir John Bell ,
University of Oxford